NIKKEI 225
39,319.44 +249.76 (+0.64%) HANG SENG
19,636.22 +82.61 (+0.42%) CRUDE OIL
79.72 -0.08 (-0.10%) GOLD FUTURES
2,429.60 -8.90 (-0.36%) DOW
39,806.77 -196.82 (-0.49%) Bitcoin GBP
56,138.48 +3,916.76 (+7.50%)
Akoya Biosciences, Inc. (AKYA)
After hours:
- GuruFocus.com
Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
Despite a revenue dip, Akoya Biosciences showcases growth in reagent sales and strategic expansions, setting a course for recovery.
- Zacks
Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates
Akoya (AKYA) delivered earnings and revenue surprises of -16.67% and 23.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Akoya Biosciences Reports First Quarter 2024 Financial Results
MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the first quarter ending March 31, 2024. Business Highlights Revenue was $18.4 million in the first quarter of 2024, compared to $21.4 million in the prior year period; a decrease of 14%. Reagents and services revenue continued to increase.Akoya announced the establishment of a new Manufacturing Center of Excellence in Marl
